A multi-domain protein system based on the HC fragment of tetanus toxin for targeting DNA to neuronal cells

被引:19
作者
Box, M
Parks, DA
Knight, A
Hale, C
Fishman, PS
Fairweather, NF
机构
[1] Univ London Imperial Coll Sci Technol & Med, Dept Biol Sci, London SW7 2AY, England
[2] Univ Maryland, Sch Med, Dept Neurol, Baltimore, MD 21201 USA
[3] Baltimore VA Med Ctr, Baltimore, MD USA
基金
英国惠康基金;
关键词
gene delivery; neuroblastoma cells; tetanus toxin; transfection;
D O I
10.1080/1061186310001634667
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
One goal of gene therapy is the targeted delivery of therapeutic genes to defined tissues. One attractive target is the central nervous system as there are several neuronal degenerative diseases which may be amenable to gene therapy. At present there is a lack of delivery systems that are able to target genes specifically to neuronal cells. Multi-domain proteins were designed and constructed to facilitate the delivery of exogenous genes to neuronal cells. Neuronal targeting activity of the proteins was achieved by inclusion of the H-C fragment of tetanus toxin (TeNT), a protein with well-characterised tropism for the central nervous system. The yeast Gal4 DNA-binding domain enabled specific binding of DNA while the translocation domain from diphtheria toxin (DT) was included to facilitate crossing of the endosomal vesicle. One multi-domain protein, containing all three of these domains, was found to transfect up to 8% of neuroblastoma N18-RE105 cells with marker genes. Monitoring the transfection by confocal microscopy indicated that this protein-DNA transfection complex is to some extent localised at the cell surface, suggesting that further improvements to translocating this membrane barrier may yield higher transfection levels. The demonstration that this multi-domain protein can target genes specifically to neuronal cells is a first step in the development of novel vectors for the delivery of genes with therapeutic potential to diseased neuronal tissues.
引用
收藏
页码:333 / 343
页数:11
相关论文
共 31 条
[1]   TRANSFER OF A FOREIGN GENE INTO THE BRAIN USING ADENOVIRUS VECTORS [J].
AKLI, S ;
CAILLAUD, C ;
VIGNE, E ;
STRATFORDPERRICAUDET, LD ;
POENARU, L ;
PERRICAUDET, M ;
KAHN, A ;
PESCHANSKI, MR .
NATURE GENETICS, 1993, 3 (03) :224-228
[2]  
[Anonymous], 1989, SYNTHETIC OLIGONUCLE
[3]   DIRECT INVIVO GENE-TRANSFER TO EPENDYMAL CELLS IN THE CENTRAL-NERVOUS-SYSTEM USING RECOMBINANT ADENOVIRUS VECTORS [J].
BAJOCCHI, G ;
FELDMAN, SH ;
CRYSTAL, RG ;
MASTRANGELI, A .
NATURE GENETICS, 1993, 3 (03) :229-234
[4]   ANTIGENIC POLYPEPTIDE FRAGMENT ISOLATED FROM TETANUS TOXIN - CHEMICAL CHARACTERIZATION, BINDING TO GANGLIOSIDES AND RETROGRADE AXONAL-TRANSPORT IN VARIOUS NEURON SYSTEMS [J].
BIZZINI, B ;
STOECKEL, K ;
SCHWAB, M .
JOURNAL OF NEUROCHEMISTRY, 1977, 28 (03) :529-542
[5]   GENE-TRANSFER INTO EXPERIMENTAL BRAIN-TUMORS MEDIATED BY ADENOVIRUS, HERPES-SIMPLEX VIRUS, AND RETROVIRUS VECTORS [J].
BOVIATSIS, EJ ;
CHASE, M ;
WEI, MX ;
TAMIYA, T ;
HURFORD, RK ;
KOWALL, NW ;
TEPPER, RI ;
BREAKEFIELD, XO ;
CHIOCCA, EA .
HUMAN GENE THERAPY, 1994, 5 (02) :183-191
[6]  
CHOWDHURY NR, 1993, J BIOL CHEM, V268, P11265
[7]   Gene therapy in the CNS [J].
Costantini, LC ;
Bakowska, JC ;
Breakefield, XO ;
Isacson, O .
GENE THERAPY, 2000, 7 (02) :93-109
[8]   CELLULAR AND HUMORAL IMMUNE-RESPONSES TO ADENOVIRAL VECTORS CONTAINING FACTOR-IX GENE - TOLERIZATION OF FACTOR-IX AND VECTOR ANTIGENS ALLOWS FOR LONG-TERM EXPRESSION [J].
DAI, YF ;
SCHWARZ, EM ;
GU, DL ;
ZHANG, WW ;
SARVETNICK, N ;
VERMA, IM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (05) :1401-1405
[9]   Long-term gene delivery into the livers of immunocompetent mice with E1/E4-defective adenoviruses [J].
Dedieu, JF ;
Vigne, E ;
Torrent, C ;
Jullien, C ;
Mahfouz, I ;
Caillaud, JM ;
Aubailly, N ;
Orsini, C ;
Guillaume, JM ;
Opolon, P ;
Delaere, P ;
Perricaudet, M ;
Yeh, P .
JOURNAL OF VIROLOGY, 1997, 71 (06) :4626-4637
[10]  
Desnick RJ, 1998, ACTA PAEDIATR JAPON, V40, P191